PC
PBH icon

Promethos Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Promethos Capital’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-180
Closed -$15.5K – 71
2025
Q1 		$15.5K Hold
180
– – 0.01% 55
2024
Q4 		$14.1K Hold
180
– – 0.01% 60
2024
Q3 		$13K Hold
180
– – ﹤0.01% 62
2024
Q2 		$12.4K Hold
180
– – ﹤0.01% 55
2024
Q1 		$13.1K Hold
180
– – 0.01% 53
2023
Q4 		$11K Buy
+180
New +$10.7K 0.01% 53

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Promethos Capital's PBH Position: Q2 2025 in Review

Promethos Capital sold out of Prestige Consumer Healthcare (PBH) in Q2 2025, closing a stake of 180 shares — an estimated $15.5K sold.

Promethos Capital first reported a position in PBH in Q4 2023 and held it in 6 quarters. The position peaked at $15.5K in Q1 2025. 378 funds tracked by Wall St. Rank hold PBH as of Q2 2025.

  • Promethos Capital reported no remaining Prestige Consumer Healthcare position as of Q2 2025 after selling out during the quarter.
  • Promethos Capital sold 180 Prestige Consumer Healthcare shares in Q2 2025, an estimated $15.5K.
  • Promethos Capital first reported a position in Prestige Consumer Healthcare in Q4 2023 and held it in 6 quarters.
  • Promethos Capital's Prestige Consumer Healthcare position peaked at $15.5K in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2025.

Based on Promethos Capital's 13F filing for Q2 2025, filed 14 Aug 2025.